Navigation Links
Reprogramming human cells without inserting genes
Date:7/29/2009

WORCESTER, Mass. A research team comprised of faculty at Worcester Polytechnic Institute's (WPI) Life Sciences and Bioengineering Center (LSBC) and investigators at CellThera, a private company also located at the LSBC, has discovered a novel way to turn on stem cell genes in human fibroblasts (skin cells) without the risks associated with inserting extra genes or using viruses. This discovery opens a new avenue for reprogramming cells that could eventually lead to treatments for a range of human diseases and traumatic injuries by coaxing a patient's own cells to repair and regenerate the damaged tissues.

The research team reported its findings in the paper "Induction of Stem Cell Gene Expression in Adult Human Fibroblasts without Transgenes," published online July 21, 2009 (in advance of September print publication) as a "fast track" paper from the journal Cloning and Stem Cells.

"We show that by manipulating culture conditions alone, we can achieve changes in fibroblasts that would be beneficial in development of patient-specific cell therapy approaches," the authors wrote in the paper.

Early on, the emerging field of regenerative medicine focused on embryonic stem cells, which are pluripotent, meaning they can grow into all the tissues of an adult organism. In the pluripotent state, several genes are known to be active, helping to control the stem cells. These genes, including OCT4, SOX2 and NANOG, are accepted as markers of pluripotency because they are active in stem cells, but become dormant once the stem cells begin to differentiate and head down the path to developing into a specific kind of cell type and tissue.

While the study of embryonic stem cells continues to yield important knowledge, research teams around the world are also working to change, or reprogram, fully-differentiated cells like skin cells, back to a more pluripotent state. Called induced pluripotent stem cells (iPS), these reprogrammed cells could
'/>"/>

Contact: Michael Cohen
mcohen@wpi.edu
508-868-4778
Worcester Polytechnic Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Yamanaka eliminates viral vector in stem cell reprogramming
2. Reprogramming the debate: stem-cell finding alters ethical controversy
3. Humans damaging the oceans
4. First genetically-engineered malaria vaccine to enter human trials
5. Humans lend a hand to critically endangered waterbird
6. Ants more rational than humans
7. University of Minnesota research leads to new technology to protect human health
8. Researchers design first model motor nerve system thats insulated and organized like the human body
9. Skin-like tissue developed from human embryonic stem cells
10. New study ranks hotspots of human impact on coastal areas
11. Springer to collaborate with the Human Genome Organization

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
(Date:11/23/2009)...t research suggests that a common oral bacterium m...ort by Nichols et al, "Unique Lipids from a Common...ands Capable of Enhancing Autoimmunity," appears i... of Pathology . , Multiple sclerosis (MS), a dis... spinal cord, affects nearly 1 in 700 people in th...
(Date:11/23/2009)... producing some of the highest resolution images o...ts have a deeper understanding how biomolecules ma...ad to a new treatment for kidney stones using biom...ov. 23 online edition of the journal Proceedings ... peptides interact with mineral surfaces by accele...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Existing Drug May Lead to ALS Treatment 59797 1Existing Drug May Lead to ALS Treatment 59797 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6
...RANSAS, TexasBacterial communities endemic to heal...d type of natural and man-made dissolved organic m...versity of Texas at Austin Marine Science Institut... , Healthy corals naturally exude a surrounding m...ria exists. Recent studies have indicated that so...
...DGE, Tenn., March 4, 2008 -- Latin American nation...world markets in coming decades, according to an O...ly. , The report, Biofuel Feedstock Assessment fo...rch conducted in support of a larger study of Worl...n U.S. Imports by the Department of Energy. The OR...
...rd minimum of Arctic sea ice, new species in the A...t climate these are only some of the results of t...r Year 2007/08. From March 10 14, 2008 the most i...he frame of the 23rd International Polar Meeting o...n to scientific highlights, also student and schoo...
Other Biology News:Dissolved organic matter in the water column may influence coral health 2Imports from Latin America may help US meet energy goals, study finds 2Imports from Latin America may help US meet energy goals, study finds 3Half time in the International Polar Year 2007-2008 2
(Date:11/24/2009)...FirstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL ...,December1stat1:45PMGMTinLondon,7:45AMUS/CST.Inter...nternetavailableat http://inve s tor.sig m a ...ccessthisfile. ,, AboutSigma-Aldrich: Sigma-...ny.Itschemicalandbiochemicalproductsandkitsareused...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasd...stday"motionsbytheU.S.BankruptcyCourtfortheDistric...iledavoluntarypetitionfor,reliefunderChapter11ofth.... , TheordersissuedbytheBankruptcyCourtallowt...hapter11proceedings.Inparticular,the,companyreceiv...
(Date:11/24/2009)...wswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),a...ercializingnovelpainmanagementtherapies,announcedt...fficer,isscheduledtopresentatthe21stAnnualPiperJaf...tTheNewYorkPalaceHotelinNewYork,NewYork. ,, Mr....illbeavailabletorespondtoquestionsduringthepresent...
(Date:11/24/2009)...-BlueMarbleEnergyCorp.announcedtodaythatthecompany...centlyawarded$2millionbyWashingtonState,sCommunity...partnershiptoconstructthestate,sfirstspecialtybioc...nvestmentwillsignificantlyspeedthedevelopmentofour..."saidBlueMarbleEnergyCEOKellyOgilvie."Wearegratefu...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...YKJAVIK, Iceland, Aug. 29 deCODE genetics,(Nasdaq... webcast of deCODE,CEO Kari Stefansson,s presentat...e Conference. The presentation will be delivered ... Seasons, Boston. The webcast can be accessed,thro...//www.decode.com, and those,interested in listeni...
...MBRIDGE, Mass., Aug. 29 Millennium,Pharmaceutical...presentation,at the Thomas Weisel Partners 2007 He...e accessed by visiting the Investors section of th... (Logo: http://www.newscom.com/cgi-bin/prnh/19991...nt events, clinical pipeline updates,and upcoming ...
...ILADELPHIA, Aug. 29 eResearchTechnology,Inc. (eRT...ized,electrocardiographic (ECG) collection and int...ael J. McKelvey, the Company,s President and,Chief...,s Chief Financial,Officer, will present at the Th...tern on September 5, 2007 in the Phillips Room at ...
Other Biology Technology:Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation 2eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th 2eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th 3
...nd is causing shortages in your laboratory or fell...an cause unwanted distractions, problems and delay... work and endeavour! Bring us your idea and let us...k under ISO 9001 quality assurance in design, deve...
...rons are cytopathic effect inhibition assays, also...include; tissue culture supernatents; serum from P...ays, one unit is defined as the quantity of interf...hic effect of viral infection by 50%. All standa...
...ia virus is a type I eukaryotic topoisomerase that...urns (also called right- and left-handed supercoil...reaction is a covalently closed, circular DNA with...A Topoisomerase I does not absolutely require Mg 2...
...ia virus is a type I eukaryotic topoisomerase that...urns (also called right- and left-handed supercoil...reaction is a covalently closed, circular DNA with...A Topoisomerase I does not absolutely require Mg 2...
Biology Products: